Gene · 4986
Papers4,507
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 4,507
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder. | Drugs | 2022 | 35133639 | PubTator, text mining | PubMed |
| Role of antioxidants and oxidative stress in the evolution of acute pancreatitis (Review). | Exp Ther Med | 2022 | 35126700 | PubTator, text mining | PubMed |
| Safety and Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome-Diarrhea With or Without Bile Acid Diarrhea: Open-Label Study. | Dig Dis Sci | 2022 | 35122592 | PubTator, text mining | PubMed |
| APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis. | Hepatol Int | 2022 | 35119627 | PubTator, text mining | PubMed |
| Long-term buprenorphine treatment for kratom use disorder: A case series. | Subst Abus | 2022 | 35112990 | PubTator, text mining | PubMed |
| Genetic and Clinical Factors Associated with Opioid Response in Chinese Han Patients with Cancer Pain: An Exploratory Cross-Sectional Study. | Pain Ther | 2022 | 35107781 | PubTator, text mining | PubMed |
| Community guidelines for GPCR ligand bias: IUPHAR review 32. | Br J Pharmacol | 2022 | 35106752 | PubTator, text mining | PubMed |
| An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects. | Pharmacol Res | 2022 | 35101565 | PubTator, text mining | PubMed |
| Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1. | Oncogene | 2022 | 35087237 | PubTator, text mining | PubMed |
| Association of prenatal alcohol exposure with offspring DNA methylation in mammals: a systematic review of the evidence. | Clin Epigenetics | 2022 | 35073992 | PubTator, text mining | PubMed |
| Novel Molecular Targets of Antidepressants. | Molecules | 2022 | 35056845 | PubTator, text mining | PubMed |
| Discovering the Potential of Natural Antioxidants in Age-Related Macular Degeneration: A Review. | Pharmaceuticals (Basel) | 2022 | 35056157 | PubTator, text mining | PubMed |
| Acute pain-related depression of operant responding maintained by social interaction or food in male and female rats. | Psychopharmacology (Berl) | 2022 | 35043215 | PubTator, text mining | PubMed |
| Current understanding of the genetics of tourette syndrome. | Biomed J | 2022 | 35042017 | PubTator, text mining | PubMed |
| How to improve the design of experimental studies in computing education: Evidence from the international assessments. | Educ Inf Technol (Dordr) | 2022 | 35039744 | PubTator, text mining | PubMed |
| Mapping the Binding Sites of UDP and Prostaglandin E2 Glyceryl Ester in the Nucleotide Receptor P2Y6. | ChemMedChem | 2022 | 35034430 | PubTator, text mining | PubMed |
| Synthesis of 8-aminomorphans with high KOR affinity. | Eur J Med Chem | 2022 | 35033825 | PubTator, text mining | PubMed |
| Dynorphin A induces membrane permeabilization by formation of proteolipidic pores. Insights from electrophysiology and computational simulations. | Comput Struct Biotechnol J | 2022 | 35024095 | PubTator, text mining | PubMed |
| Effect of removal of the 14-hydroxy group on the affinity of the 4,5-epoxymorphinan derivatives for orexin and opioid receptors. | Bioorg Med Chem Lett | 2022 | 35007722 | PubTator, text mining | PubMed |
| Evaluation of animal model congruence to human depression based on large-scale gene expression patterns of the CNS. | Sci Rep | 2022 | 34997033 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4986/papers?page=51